One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
Price : 100$- Special Price : 50$
Apples, Oranges, and ESOPEC Recurrence Patterns.
doi : 10.1200/JCO-25-01552
Volume 43(32) pgs. 3429-3547 November 10, 2025
Bringing Trustworthy Artificial Intelligence to the Clinical Forefront at JCO : A Guide for Studies Testing Artificial Intelligence Models.
doi : 10.1200/JCO-25-01939
Bridging the Gap: The Evolving Landscape of CNS Management in Small Cell Lung Cancer: Prophylactic Cranial Irradiation in the Modern Era.
doi : 10.1200/JCO-25-01817
Precision Oncology and Modernizing Evidence Standards: A Critical Commentary on the Cochrane Review.
doi : 10.1200/JCO-25-01475
Recurrence Patterns of Esophageal Adenocarcinoma in the Phase III ESOPEC Trial Comparing Perioperative Chemotherapy With Preoperative Chemoradiotherapy.
doi : 10.1200/JCO-25-00948
Neoadjuvant CTLA-4/PD-(L)1 Blockade Versus Surgery +/- Chemotherapy in Deficient Mismatch Repair/Microsatellite Instability-High Resectable Gastroesophageal Adenocarcinoma: Individual Patient Data Pooled Analysis.
doi : 10.1200/JCO-25-00447
Foundation Model for Predicting Prognosis and Adjuvant Therapy Benefit From Digital Pathology in GI Cancers.
doi : 10.1200/JCO-24-01501
Deep Learning Model for Breast Shear Wave Elastography to Improve Breast Cancer Diagnosis (INSPiRED 006): An International, Multicenter Analysis.
doi : 10.1200/JCO-24-02681
Development and Validation of an Artificial Intelligence Digital Pathology Biomarker to Predict Benefit of Long-Term Hormonal Therapy and Radiotherapy in Men With High-Risk Prostate Cancer Across Multiple Phase III Trials.
doi : 10.1200/JCO.24.00365
Efficacy and Safety of BL-B01D1 in Patients With Locally Advanced or Metastatic Urothelial Carcinoma: A Phase II Clinical Trial.
doi : 10.1200/JCO-25-00109
Hippocampal Avoidance During Prophylactic Cranial Irradiation for Patients With Small Cell Lung Cancer: Randomized Phase II/III Trial NRG-CC003.
doi : 10.1200/JCO-25-00221
Inotuzumab Ozogamicin Then Blinatumomab for Older Adults With Newly Diagnosed B-Cell ALL: Alliance Study A041703 Cohort 1 Results.
doi : 10.1200/JCO-25-00307
End Points for the Next-Generation Bladder-Sparing Perioperative Trials for Patients With Muscle-Invasive Bladder Cancer.
doi : 10.1200/JCO-25-01608
Reply to: Response to Neoadjuvant Chemotherapy and Breast Cancer Subtypes.
doi : 10.1200/JCO-25-01972
Erratum: Identifying Patients With Low Relapse Rate Despite High-Risk Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer: Development and Validation of a Clinicopathologic Assay.
doi : 10.1200/JCO-25-02272
Erratum: Efficacy and Safety of Avutometinib +/- Defactinib in Recurrent Low-Grade Serous Ovarian Cancer: Primary Analysis of ENGOT-OV60/GOG-3052/RAMP 201.
doi : 10.1200/JCO-25-02377
